Your browser doesn't support javascript.
loading
In silico modelling of stroke volume, cardiac output and systemic vascular resistance in cardiovascular safety pharmacology studies by telemetry.
Champeroux, Pascal; Thireau, Jérôme; Le Guennec, Jean-Yves; Fares, Raafat.
Afiliación
  • Champeroux P; ERBC France, Chemin de Montifault, 18800 Baugy, France. Electronic address: pchamperoux@erbc-group.com.
  • Thireau J; Laboratoire PHYMEDEXP, Université de Montpellier, INSERM, CNRS, 371 Avenue du doyen G. Giraud, 34295 Montpellier, Cedex 05, France.
  • Le Guennec JY; Laboratoire PHYMEDEXP, Université de Montpellier, INSERM, CNRS, 371 Avenue du doyen G. Giraud, 34295 Montpellier, Cedex 05, France.
  • Fares R; ERBC France, Chemin de Montifault, 18800 Baugy, France.
J Pharmacol Toxicol Methods ; 127: 107512, 2024.
Article en En | MEDLINE | ID: mdl-38719163
ABSTRACT
The principle of proportionality of the systolic area of the central aortic pressure to stroke volume (SV) has been long known. The aim of the present work was to evaluate an in silico solution derived from this principle for modelling SV (iSV model) in cardiovascular safety pharmacology studies by telemetry. Blood pressure was measured in the abdominal aorta in accordance with standard practice. Central aortic pressure was modelled from the abdominal aortic pressure waveform using the N-point moving average (NPMA) method for beat-to-beat estimation of SV. First, the iSV was compared to the SV measured by ultrasonic flowmetry in the ascending aorta (uSV) after various pharmacological challenges in beagle dogs anaesthetised with etomidate/fentanyl. The iSV showed minimal bias (0.2 mL i.e. 2%) and excellent agreement with uSV. Then, previous telemetry studies including reference vasoactive and inotropic compounds were retrospectively reanalysed to model drug effects on stroke volume (iSV), cardiac output (iCO) and systemic vascular resistance (iSVR). Among them, the examples of nicardipine and isoprenaline highlight risks of erroneous or biased estimation of drug effects from the abdominal aortic pressure due to pulse pressure amplification. Furthermore, the examples of verapamil, quinidine and moxifloxacin show that iSV, iCO and iSVR are earlier biomarkers than blood pressure itself for predicting drug effect on blood pressure. This in silico modelling approach included in vivo telemetry safety pharmacology studies can be considered as a New Approach Methodology (NAM) that provides valuable additional information and contribute to improving non-clinical translational research to the clinic.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Volumen Sistólico / Telemetría / Resistencia Vascular / Simulación por Computador / Gasto Cardíaco Límite: Animals Idioma: En Revista: J Pharmacol Toxicol Methods Asunto de la revista: FARMACOLOGIA / TOXICOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Volumen Sistólico / Telemetría / Resistencia Vascular / Simulación por Computador / Gasto Cardíaco Límite: Animals Idioma: En Revista: J Pharmacol Toxicol Methods Asunto de la revista: FARMACOLOGIA / TOXICOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos